Why the study?
Is the WATCHMAN left atrial appendage closure device safe and effective in Japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism?
Is the WATCHMAN left atrial appendage closure device safe and effective in Japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism?
The WATCHMAN LAA closure device is safe and effective for stroke prevention in Japanese patients with nonvalvular atrial fibrillation, consistent with global trial data.
No takes yet. Share an insight, caveat, or question.
LAA closure may be feasible in Japanese NVAF patients; extends Western trial data but leaves open need for randomized confirmation.
Aonuma et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: